APAC IPOs & Placements

Zhen Zhou, Toh

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Suzhou Basecare Medical / Equity Capital Markets

<p><a href="https://www.smartkarma.com/entities/suzhou-basecare-medical-corporation-limited" target="_blank" data-smartkarma-citation="entities:31087:1" rel="noopener">Suzhou Basecare Medical (MED CH)</a>  is looking to raise about US$250m in its upcoming Hong Kong IPO. </p><p>Basecare Medical (Basecare) is a genetic testing solutions provider assisted reproduction in China. The company’s current core product, PGT-A kit, is the first and only third-generation IVF genetic test kit to be approved by the National Medical Products Administration (NMPA) in February 2020.</p>

Suzhou Basecare Medical (MED CH)  is looking to raise about US$250m in its upcoming Hong Kong IPO. Basecare Medical (Basecare) is a genetic testing solutions provider assisted reproduction in China. The company’s current core product, PGT-A kit, is the first and only third-generation IVF genetic test kit to be approved by the National Medical Products Administration (NMPA) in February 2020.

Basecare Medical (贝康医疗) Pre-IPO - Genetic Testing Leader in China